Pila Pharma Danmark ApS
CVR 39023636 · Private limited company (ApS) · Active · Low risk
Pila Pharma Danmark ApS is a Private limited company (ApS), founded on , based in København Ø. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 2.6m and a net result of DKK -3.8m. CEO: Dorte Xenia Gram.
Bankruptcy risk for Pila Pharma Danmark ApS
0.2 × the average (1.41%) · higher risk than 49% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39023636
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (9 years)
- Address
- c/o Hanghøj, Vardegade 11, 6.
2100 København Ø - Municipality
- København
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 50k
- Auditor
- PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 67.5% |
| Current ratio | 306% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 4 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -4.8m | DKK -3.9m | DKK -4.4m |
| Net profit | DKK -3.8m | DKK -3.1m | DKK -3.8m |
| Equity | DKK 2.6m | DKK 336k | DKK 1.4m |
| Total assets | DKK 3.8m | DKK 2.1m | DKK 2.2m |
| Cash | DKK 2.3m | DKK 995k | – |
| Short-term debt | DKK 1.3m | DKK 1.8m | – |
| Avg. employees | 0 | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Andre erklæringer uden sikkerhed · PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 117 | ||
| 1 Jan 2024 – 31 Dec 2024 | 90 | ||
| 1 Jan 2023 – 31 Dec 2023 | 136 | ||
| 1 Jan 2022 – 31 Dec 2022 | 160 | ||
| 1 Jan 2021 – 31 Dec 2021 | 138 | ||
| 1 Jan 2020 – 31 Dec 2020 | 152 | ||
| 1 Jan 2019 – 31 Dec 2019 | 132 | ||
| 18 Oct 2017 – 31 Dec 2018 | 151 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Dorte Xenia Gram | Current | |
| Owner (100%) | Pila Pharma AB | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Pila Pharma AB | Current |
The CEOs' other companies
Dorte Xenia Gram – 1 other companies
- XENIA PHARMA ApS Active
Address history (2 moves)
| c/o Hanghøj, Vardegade 11, 6., 2100 København Ø | |
| c/o Gus Travel, Gustav Hanghøj Gram, Vardegade 11, 6., 2100 København Ø | |
| c/o Xenia Pharma ApS, Ole Maaløes Vej 3, 2200 København N |
Other companies at the same address
- HumanEffekt ApS Opløst
- Kordt ApS Opløst
- La Regista ApS Active
- XENIA PHARMA ApS Active
Similar companies in København
- H. LUNDBECK A/S Valby
- GUNNAR KJEMS ApS København K
- Tetrapharm Therapeutics ApS København S
- Tetrapharm Bioengineering ApS København S
- Luvalis Pharma ApS Vanløse
- NeuroVersis Therapeutics ApS København K
- QuantumCell ApS København K
- Vautia Therapeutics ApS København K
- Corxel Pharmaceuticals Denmark ApS København V
- Dispersome IP ApS København Ø
- Maddox Pharma Swiss ApS København S
- Gefjon Pharma ApS København N
Questions and answers about Pila Pharma Danmark ApS
Has Pila Pharma Danmark ApS gone bankrupt?
No, Pila Pharma Danmark ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Pila Pharma Danmark ApS?
Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.
Who is the CEO of Pila Pharma Danmark ApS?
Dorte Xenia Gram is the CEO of Pila Pharma Danmark ApS.
Who is the auditor of Pila Pharma Danmark ApS?
Pila Pharma Danmark ApS most recently used PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab.
When was Pila Pharma Danmark ApS founded?
Pila Pharma Danmark ApS was founded on 18 October 2017.
What is the equity of Pila Pharma Danmark ApS?
Equity was DKK 2.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.